- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07334678
TROPIS Versus Coring Out Fistulectomy in High Anal Fistula (TROCO-HAF)
Early Results of Transanal Opening of the Intersphincteric Space (TROPIS) Versus Coring Out Fistulectomy in Management of High Anal Fistulas: A Randomized Clinical Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Fistula-in-ano is an abnormal epithelialized tract connecting the anal canal to the perianal skin, most commonly caused by cryptoglandular infection. High anal fistulas, involving more than one-third of the sphincter complex, carry a significant risk of postoperative incontinence when treated with fistulotomy. As a result, sphincter-preserving techniques have introduced.
Coring out fistulectomy allows excision of the fistulous tract while preserving sphincter integrity but has variable recurrence rates. TROPIS involves transanal opening of the intersphincteric space with complete preservation of the external anal sphincter and has shown high success rates in recent studies.
This prospective randomized clinical trial compares TROPIS and coring out fistulectomy regarding Failure rate (defined as failure of healing or recurrence of anal fistula), operative time, time for wound healing and postoperative complications including fecal incontinence.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Ahmed Mohamed Abdelaal, Lecturer
- Phone Number: +201118732767
- Email: drabdelaal90@gmail.com
Study Locations
-
-
Al-Manial Cairo
-
Cairo, Al-Manial Cairo, Egypt, 11451
- Recruiting
- Faculty of medicine Cairo University
-
Contact:
- Ahmed Mohamed Abdelaal, Lecturer
- Phone Number: +201118732767
- Email: drabdelaal90@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients with high anal fistula ( involving more than 1/3 of the sphincter complex), whether de novo or recurrent
Exclusion Criteria:
- Patients with fistula secondary to malignancy, inflammatory bowel disease, trauma or radiation
- Patients with Low anal fistula
- Patient with preoperative fecal incontinence
- Previous levator ani muscle injury
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Transanal Opening of the Intersphincteric Space (TROPIS)
patient with high anal fistula will be treated with Transanal Opening of the Intersphincteric Space (TROPIS)
|
The fistula tracts on both sides of the External anal sphincter (EAS) are separately dealt with.
A curved artery forceps is inserted in the fistula tract in the intersphincteric space through the internal opening.The mucosa and the internal sphincter overlying the artery forceps are then incised with electrocautery.
The edges of the resulting wound are trimmed and A gutter is made inferiorly from the opened-up intersphincteric space to the anal verge to facilitate drainage from the intersphincteric space wound in the postoperative period.The fistula tract lateral to (outside) the EAS will be excised till the external anal sphincter.
|
|
Active Comparator: Coring Out Fistulectomy
patient with high anal fistula will be treated with Coring Out Fistulectomy
|
Incision was made around external opening.Coring out the fistulous track using a combination of cutting and coagulation diathermy from external opening to internal opening with closure of internal opening
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Compares Failure rate of TROPIS versus Coring Out fistulectomy in high fistula
Time Frame: Up to 4 months postoperatively
|
Compares Failure rate of TROPIS versus Coring Out fistulectomy in high fistula (failure of healing or recurrence of anal fistula), Early results
|
Up to 4 months postoperatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Operative time
Time Frame: During surgery
|
compare time of operation between both procedure
|
During surgery
|
|
Hospitalization period
Time Frame: From surgery until discharge
|
compare how many days patients stay in hospital postoperatively in both groups
|
From surgery until discharge
|
|
surgical site infection
Time Frame: Up to 4 months postoperatively
|
compare surgical site infection in both groups
|
Up to 4 months postoperatively
|
|
Time for wound Healing
Time Frame: Up to 4 months postoperatively
|
Time for wound Healing in both groups
|
Up to 4 months postoperatively
|
|
Postoperative bleeding
Time Frame: Up to 4 months postoperatively
|
compare Postoperative bleeding in both groups
|
Up to 4 months postoperatively
|
|
postoperative fecal incontinence
Time Frame: Up to 4 months postoperatively
|
compare post postoperative fecal incontinence in both groups
|
Up to 4 months postoperatively
|
|
Time to return to normal activity
Time Frame: Up to 4 months postoperatively
|
Compare Time to return to normal activity in both groups
|
Up to 4 months postoperatively
|
|
Postoperative urine retention
Time Frame: Within 48 hours postoperatively
|
compare postoperative urine retention in both groups
|
Within 48 hours postoperatively
|
|
Pain intensity
Time Frame: At day 1 and day 7 postoperatively
|
Compare Pain intensity measured using Visual Analogue Scale between both groups (Visual Analogue Scale for Pain: ranges from 0 to 10 .
Higher scores indicate a worse outcome {greater pain intensity}).
|
At day 1 and day 7 postoperatively
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Haitham M.Azmy Basiouny, Lecturer, Cairo university
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- MS-311-2025
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on High Anal Fistula
-
Cairo UniversityRecruiting
-
Assiut UniversityActive, not recruiting
-
Chinese University of Hong KongTerminated
-
China-Japan Friendship HospitalCompletedHigh Complex Anal FistulaChina
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityCompletedAnal Fistula | Anal Fistula SurgeryChina
-
Zagazig UniversityCompletedTranssphincteric Anal FistulaEgypt
-
National and Kapodistrian University of AthensRecruitingAnal Fistula | Perianal Fistula | Anal Fistula SurgeryGreece
-
Assiut UniversityNot yet recruitingAnal Fistula | Surgery Timing | Anal Fistula Surgery
-
F Care Systems NVRecruiting
-
Societa Italiana di Chirurgia ColoRettaleTerminated
Clinical Trials on Transanal opening of intersphincteric space (TROPIS)
-
Cairo UniversityRecruiting